(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 10.7% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.82%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Mckesson's revenue in 2024 is $301,506,000,000.On average, 6 Wall Street analysts forecast MCK's revenue for 2025 to be $44,585,318,273,387, with the lowest MCK revenue forecast at $43,662,952,344,248, and the highest MCK revenue forecast at $46,945,360,497,757. On average, 6 Wall Street analysts forecast MCK's revenue for 2026 to be $48,092,490,181,660, with the lowest MCK revenue forecast at $46,289,528,023,988, and the highest MCK revenue forecast at $52,503,852,150,585.
In 2027, MCK is forecast to generate $56,321,827,914,515 in revenue, with the lowest revenue forecast at $56,321,827,914,515 and the highest revenue forecast at $56,321,827,914,515.